Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

FDG-PET/CT identified distant metastases and synchronous cancer in squamous cell carcinoma of the head and neck: the impact of smoking and P16-s

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Patient-reported outcome during radiotherapy for head and neck cancer: the use of different PRO questionnaires

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Assessing competence in cochlear implant surgery using the newly developed Cochlear Implant Surgery Assessment Tool

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Use of simulation-based training of surgical technical skills among ENTs: an international YO-IFOS survey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Inter-observer and intra-observer agreement in drug-induced sedation endoscopy — a systematic approach

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association of apolipoprotein M and sphingosine-1-phosphate with brown adipose tissue after cold exposure in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: Whole-body FDG-PET-CT is widely used at diagnosis of squamous cell carcinoma of the head and neck (SCCHN) but may identify suspicious lesions outside the neck that require investigation. This study evaluated the impact of smoking and P16-status on the incidence of malignant disease outside the head and neck region in newly diagnosed patients with SCCHN.

METHODS: All PET-positive foci outside the head-neck area were registered in 1069 patients planned for postoperative or curative intent radiotherapy with whole-body FDG-PET/CT from 2006 to 2012. All patient files were retrospectively investigated and clinical parameters, tobacco use, HPV (P16)-status and subsequent malignant disease registered.

RESULTS: Malignancy outside the neck was diagnosed in 9% of smokers, 2% of never-smokers, and 5% of patients with P16-positive oropharyngeal squamous cell carcinoma (OPSCC). Clinically suspicious PET-positive foci outside the head-neck were malignant in 55% of smokers, 34% of never-smokers, and in 38% of P16-pos OPSCC. All but two patients with cancer occurring outside the head and neck region were smokers.

CONCLUSION: Malignancy outside the neck at diagnosis was more frequent in smokers compared to non-smokers or P16-pos OPSCC. A high proportion of clinically suspicious PET-positive foci were non-malignant.

OriginalsprogEngelsk
TidsskriftEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Vol/bind279
Udgave nummer1
Sider (fra-til)521-526
Antal sider6
ISSN0003-9195
DOI
StatusUdgivet - jan. 2022

ID: 66309771